Search clinical trials for: 177Lu-DOTA-TLX591
Total 2076 results
-
Telix International Pty LtdNot yet recruiting
-
Telix Pharmaceuticals (Innovations) Pty LimitedActive, not recruiting
-
Telix International Pty LtdCompletedMetastatic Prostate CancerAustralia
-
Telix Pharmaceuticals (Innovations) Pty LimitedCompletedMetastatic Prostate CancerAustralia
-
The First Affiliated Hospital of Xiamen UniversityRecruiting177Lu-DOTA-FAPI | 68Ga-DOTA-FAPI | TheranosticChina
-
Y-mAbs TherapeuticsNot yet recruiting
-
The First Affiliated Hospital of Xiamen UniversityRecruitingRefractory Solid TumorChina
-
University of California, DavisNational Institutes of Health (NIH)RecruitingMetastatic CancerUnited States
-
Instituto Nacional de Cancerologia, ColumbiaCompleted
-
Peking Union Medical College HospitalRecruitingNeuroendocrine TumorsChina
-
Y-mAbs TherapeuticsRecruitingSarcoma | SCLC | Malignant MelanomaUnited States
-
University of California, DavisUnited States Department of DefenseRecruitingMetastatic Nonsmall Cell Lung CancerUnited States
-
University of California, DavisRecruitingLocally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States
-
The First Affiliated Hospital of Xiamen UniversityRecruitingRefractory Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell CarcinomaChina
-
Y-mAbs TherapeuticsWithdrawnSolid Tumor, Adult | Leptomeningeal MetastasisUnited States, United Kingdom
-
CHU de Quebec-Universite LavalRecruitingNeuroendocrine Tumors | Carcinoma, Neuroendocrine | Carcinoid TumorCanada
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Unknown
-
OHSU Knight Cancer InstituteNovartis; Oregon Health and Science UniversityNot yet recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMetastatic Adrenal Gland Pheochromocytoma | Stage III Thyroid Gland Medullary Carcinoma AJCC v8 | Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 | Locally Advanced Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Metastatic Parathyroid Gland Carcinoma and other conditionsUnited States
-
Telix Pharmaceuticals (Innovations) Pty LimitedMerck KGaA, Darmstadt, GermanyRecruitingAdvanced Solid Tumor | Solid Tumor, Adult | Advanced Renal Cell CarcinomaAustralia
-
IpsenTerminatedGastric Cancer | Colorectal Cancer | Bone Cancer | Squamous Cell Carcinoma of the Head and Neck | Advanced Cancer | Recurrent Disease | Pancreatic Ductal Adenocarcinoma | Metastatic TumoursUnited States, France, Belgium, Switzerland, Netherlands
-
Lund University HospitalCompletedNeuroendocrine Tumors | Liver MetastasesSweden
-
First Affiliated Hospital of Fujian Medical UniversityRecruitingMetastasis | Tumor | Positron-Emission TomographyChina
-
Memorial Sloan Kettering Cancer CenterCompletedNeuroendocrine TumorsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Adenoid Cystic Carcinoma Research Foundation; Progenics Pharmaceuticals, Inc.Not yet recruitingAdenoid Cystic CarcinomaUnited States
-
University Hospital, Basel, SwitzerlandSwiss Cancer LeagueRecruiting
-
Novartis PharmaceuticalsRecruitingGlioblastomaSpain, Switzerland, France, Portugal, United States
-
Peking UniversityNot yet recruiting
-
Molecular Targeting Technologies, Inc.ClinSmartRecruitingNeuroendocrine TumorsUnited States
-
The First Affiliated Hospital of Xiamen UniversityRecruiting
-
Yantai LNC Biotechnology Singapore PTE. LTD.Not yet recruitingMetastatic Castration-resistant Prostate Cancer, mCRPC
-
Yantai LNC Biotechnology Singapore PTE. LTD.Recruiting
-
Peking Union Medical College HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Peter MacCallum Cancer Centre, AustraliaRecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerAustralia
-
Peter MacCallum Cancer Centre, AustraliaRecruitingNeuroendocrine TumorsAustralia
-
Novartis PharmaceuticalsNot yet recruitingMetastatic Neuroendocrine Prostate Cancer
-
Sue O'DorisioAdvanced Accelerator ApplicationsWithdrawnNeuroendocrine Tumors | Pheochromocytoma | ParagangliomaUnited States
-
Norroy Bioscience Co., LTDRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Y-mAbs TherapeuticsTerminatedMedulloblastoma, ChildhoodUnited States, Spain, United Kingdom, Denmark, Netherlands
-
Peter MacCallum Cancer Centre, AustraliaEndocyte; Movember Foundation; Medical Research Future Fund; E.J. Whitten Foundation...Active, not recruitingProstatic NeoplasmsAustralia
-
Nordic NanovectorWithdrawnNon-Hodgkin LymphomaGermany
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Paul Scherrer Institute (PSI)RecruitingNeuroendocrine Neoplasia's (NENs) | Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)Switzerland
-
Advanced Accelerator ApplicationsApproved for marketingNeuroendocrine TumorsUnited States
-
Sinotau Pharmaceutical GroupRecruitingProstate CancerChina
-
FutureChemCompletedMetastatic Castration-resistant Prostate CancerKorea, Republic of
-
Affiliated Hospital of Jiangnan UniversityRecruiting
-
Affiliated Hospital of Jiangnan UniversityNot yet recruitingSolid Tumor, AdultChina
-
Peking Union Medical College HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingMetastatic Castration-resistant Prostate CancerChina
-
M.D. Anderson Cancer CenterBlue Earth TherapeuticsRecruiting